Hypoxanthine-13C2,15N structure
|
Common Name | Hypoxanthine-13C2,15N | ||
---|---|---|---|---|
CAS Number | 1330265-04-7 | Molecular Weight | 139.09 | |
Density | 1.9±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C313C2H4N315NO | Melting Point | >300° C (dec.) | |
MSDS | N/A | Flash Point | N/A |
Use of Hypoxanthine-13C2,15NHypoxanthine-13C2,15N is a 15N-labeled and 13C-labled DL-Cystine[1]. |
Name | Hypoxanthine-¹³C2,¹⁵N |
---|---|
Synonym | More Synonyms |
Description | Hypoxanthine-13C2,15N is a 15N-labeled and 13C-labled DL-Cystine[1]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
References |
Density | 1.9±0.1 g/cm3 |
---|---|
Melting Point | >300° C (dec.) |
Molecular Formula | C313C2H4N315NO |
Molecular Weight | 139.09 |
Exact Mass | 139.042252 |
Index of Refraction | 1.903 |
6-Hydroxypurine-13C2,15N |
(4,5-13C2,7-15N)-3,9-Dihydro-6H-purin-6-one |
1,9-Dihydro-6H-purin-6-one-13C2,15N |
3H-Purin-6-ol-13C2,15N |
6-Hydroxy-1H-purine-13C2,15N |
6H-Purin-6-one-4,5-13C2-7-15N, 3,9-dihydro- |